Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

Transarterial chemoembolization (TACE) using a drug-eluting bead (DEB-TACE) for hepatocellular carcinoma (HCC) is a new treatment method. We report on a case of delayed intratumoral hemorrhage after DEB-TACE. An 81-year-old male with hepatitis C virus-related cirrhosis was diagnosed with a HCC of 35...

Full description

Bibliographic Details
Main Authors: Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Yu Ogino, Tomoko Umakoshi, Yasushi Matsukiyo, Michio Kogame, Teppei Matsui, Yoshinori Kikuchi, Yoshinori Igarashi, Yasukiyo Sumino
Format: Article
Language:English
Published: Karger Publishers 2014-11-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/369005
_version_ 1828850603841814528
author Kazue Shiozawa
Manabu Watanabe
Takashi Ikehara
Yu Ogino
Tomoko Umakoshi
Yasushi Matsukiyo
Michio Kogame
Teppei Matsui
Yoshinori Kikuchi
Yoshinori Igarashi
Yasukiyo Sumino
author_facet Kazue Shiozawa
Manabu Watanabe
Takashi Ikehara
Yu Ogino
Tomoko Umakoshi
Yasushi Matsukiyo
Michio Kogame
Teppei Matsui
Yoshinori Kikuchi
Yoshinori Igarashi
Yasukiyo Sumino
author_sort Kazue Shiozawa
collection DOAJ
description Transarterial chemoembolization (TACE) using a drug-eluting bead (DEB-TACE) for hepatocellular carcinoma (HCC) is a new treatment method. We report on a case of delayed intratumoral hemorrhage after DEB-TACE. An 81-year-old male with hepatitis C virus-related cirrhosis was diagnosed with a HCC of 35 mm in diameter in S5 detected by dynamic computed tomography (CT) and contrast-enhanced ultrasonography (CEUS). DEB-TACE with DC Bead® and epirubicin hydrochloride was performed because the patient declined to undergo surgical resection. The treatment was completed, and the course after DEB-TACE was favorable. However, right hypochondriac pain suddenly developed about 1 month after DEB-TACE. Unenhanced CT showed an increase of the tumor diameter and intratumoral high-intensity area, which was not enhanced in the arterial phase. CEUS performed at the time of right hypochondriac pain (5 weeks after DEB-TACE) showed nonenhancement of almost the entire tumor in the vascular phase. The cause of the symptom may have been DEB-TACE-associated intratumoral hemorrhage. Tumor hemorrhage has been reported after DEB-TACE with tumors >5 cm in diameter, and the tumor locations were subcapsular in all previous reports. There has been no case of a tumor with a diameter <5 cm distinct from the subcapsular, as was observed in our patient. Incomplete embolization might be the cause of the intratumoral hemorrhage experienced by this case presenting a few risks. To obtain the therapeutic effect of DEB-TACE while preventing the adverse events, it may be important to understand the characteristics of the beads and to apply the appropriate embolization to each individual case.
first_indexed 2024-12-12T23:15:22Z
format Article
id doaj.art-a2c3d35e96c342bca8bb9ad2b888455c
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-12-12T23:15:22Z
publishDate 2014-11-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-a2c3d35e96c342bca8bb9ad2b888455c2022-12-22T00:08:28ZengKarger PublishersCase Reports in Oncology1662-65752014-11-017373974510.1159/000369005369005Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular CarcinomaKazue ShiozawaManabu WatanabeTakashi IkeharaYu OginoTomoko UmakoshiYasushi MatsukiyoMichio KogameTeppei MatsuiYoshinori KikuchiYoshinori IgarashiYasukiyo SuminoTransarterial chemoembolization (TACE) using a drug-eluting bead (DEB-TACE) for hepatocellular carcinoma (HCC) is a new treatment method. We report on a case of delayed intratumoral hemorrhage after DEB-TACE. An 81-year-old male with hepatitis C virus-related cirrhosis was diagnosed with a HCC of 35 mm in diameter in S5 detected by dynamic computed tomography (CT) and contrast-enhanced ultrasonography (CEUS). DEB-TACE with DC Bead® and epirubicin hydrochloride was performed because the patient declined to undergo surgical resection. The treatment was completed, and the course after DEB-TACE was favorable. However, right hypochondriac pain suddenly developed about 1 month after DEB-TACE. Unenhanced CT showed an increase of the tumor diameter and intratumoral high-intensity area, which was not enhanced in the arterial phase. CEUS performed at the time of right hypochondriac pain (5 weeks after DEB-TACE) showed nonenhancement of almost the entire tumor in the vascular phase. The cause of the symptom may have been DEB-TACE-associated intratumoral hemorrhage. Tumor hemorrhage has been reported after DEB-TACE with tumors >5 cm in diameter, and the tumor locations were subcapsular in all previous reports. There has been no case of a tumor with a diameter <5 cm distinct from the subcapsular, as was observed in our patient. Incomplete embolization might be the cause of the intratumoral hemorrhage experienced by this case presenting a few risks. To obtain the therapeutic effect of DEB-TACE while preventing the adverse events, it may be important to understand the characteristics of the beads and to apply the appropriate embolization to each individual case.http://www.karger.com/Article/FullText/369005Drug-eluting beadContrast-enhanced ultrasonographyTransarterial chemoembolizationHepatocellular carcinomaIntratumoral hemorrhage
spellingShingle Kazue Shiozawa
Manabu Watanabe
Takashi Ikehara
Yu Ogino
Tomoko Umakoshi
Yasushi Matsukiyo
Michio Kogame
Teppei Matsui
Yoshinori Kikuchi
Yoshinori Igarashi
Yasukiyo Sumino
Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Case Reports in Oncology
Drug-eluting bead
Contrast-enhanced ultrasonography
Transarterial chemoembolization
Hepatocellular carcinoma
Intratumoral hemorrhage
title Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
title_full Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
title_fullStr Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
title_full_unstemmed Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
title_short Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
title_sort delayed intratumoral hemorrhage after drug eluting bead transarterial chemoembolization for hepatocellular carcinoma
topic Drug-eluting bead
Contrast-enhanced ultrasonography
Transarterial chemoembolization
Hepatocellular carcinoma
Intratumoral hemorrhage
url http://www.karger.com/Article/FullText/369005
work_keys_str_mv AT kazueshiozawa delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT manabuwatanabe delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT takashiikehara delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT yuogino delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT tomokoumakoshi delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT yasushimatsukiyo delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT michiokogame delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT teppeimatsui delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT yoshinorikikuchi delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT yoshinoriigarashi delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma
AT yasukiyosumino delayedintratumoralhemorrhageafterdrugelutingbeadtransarterialchemoembolizationforhepatocellularcarcinoma